Search

everythinglearnresearchcommunity

for

Search:↓

The article suggests that targeting specific immune pathways could help control and treat the skin disease hidradenitis suppurativa.

Antiandrogen drugs can reduce PSA levels in women with excess hair, suggesting PSA is a sign of male hormone activity in women.

A mutation in the iRhom2 gene causes hairless mice due to abnormal hair follicle development.

Testosterone may both worsen and protect against COVID-19 effects in men.

COVID-19 may affect male fertility and women might have better outcomes due to hormonal and immune differences.

A new mutation in the ST14 gene causes a rare skin and hair disorder in a specific family.

COVID-19 patients may experience hair loss, but it's not linked to their age or sex.

PSA levels could help detect illegal steroid use in female athletes but face challenges like cost and PCOS prevalence.

Certain genetic differences may affect how likely someone is to get COVID-19 and how severe it might be.

PSA levels are higher in women with PCOS, but FAI is a more accurate marker for diagnosis.

Certain mutations in the PADI3 gene may increase the risk of developing a type of scarring hair loss common in women of African descent.

TMPRSS2 is crucial for COVID-19 infection and is a potential target for treatment.

The conclusion is that certain genetic factors and blood types may affect COVID-19 severity, but changes in ACE2 and TMPRSS2 genes are not clearly linked to it.

The drugs finasteride and dutasteride reduce low-grade prostate cancers but may double the risk of high-grade cancers.

Women with conditions like PCOS may have a higher risk of COVID-19, but treatments like isotretinoin could help those with acne.

Men have worse COVID-19 outcomes than women due to genetic and hormonal differences.

PSA could be a marker for hyperandrogenism in women, but more research is needed.

PSA might help diagnose PCOS and related skin issues, but more research is needed.

Androgens may worsen COVID-19 and hair loss could indicate the disease's severity.

PrEP doesn't increase STI risk in high-risk men, anti-androgen drugs may lower ICU admission for male COVID-19 patients, a 3-point injection is better for crow's feet, and the 'Geriatric-8' tool could help assess frailty in older skin cancer patients.

Swedish men with the E213 A-allele of the androgen receptor have a lower risk of prostate cancer.

Certain gene mutations can weaken the skin barrier and, when combined with environmental factors, lead to eczema and severe itching.

Terbinafine is more effective than itraconazole for toenail fungus, especially in older patients, and debridement improves its effectiveness.

Touching cats can increase the risk of getting a fungal scalp infection, especially in boys and kids over 5.

Blocking the virus's entry into cells by targeting certain pathways could lead to early COVID-19 treatments.

The conclusion is that individual differences in COVID-19 severity are influenced by factors like age, sex, race, and genetics, which are important for personalized medicine.

Anti-androgens, like finasteride, dutasteride, and spironolactone, may lessen the severity of COVID-19 in men, leading to fewer ICU admissions.

5-alpha-reductase inhibitors may reduce COVID-19 symptoms in bald males.

AGA linked to worse COVID-19 outcomes in men.

Having a lot of gray hair and hair loss are linked to more severe COVID-19.